The GLP-1 pathway may play a crucial role in ALS by facilitating neurogenesis and neuroplasticity, with GLP-1 activators showing promise as targets for neuroprotection in ALS to slow disease progression and improve patient survival in neurodegenerative diseases, but further studies are needed [73]. This evidence concerns the gene GCG and neurodegenerative disease.